Franco Laghi, MD, a professor and pulmonologist affiliated with Loyola University Medical Center as well as the Edward Hines, Jr. Veterans Affairs Hospital in Maywood, Illinois, discussed the use of home-based exercise rehabilitation programs for veterans with long COVID-19, and patient reluctance to come to a medical facility during the pandemic.
Insufficient physical rehabilitation programs for patients with COVID-19 and their hesitancy to come to medical facilities during the COVID-19 pandemic were reasons why this study was conducted, said Franco Laghi, MD, a professor and pulmonologist affiliated with Loyola University Medical Center and Edward Hines, Jr. Veterans Affairs Hospital in Maywood, Illinois.
The following questions are regarding an abstract titled “A Home-based, Remotely Monitored Program to Improve Physical Activity in Patients With Long COVID” presented at the American Thorasic Society's 2023 annual meeting.
Transcript
Why did you study home-based physical activity in patients with long COVID-19?
Patients with COVID-19, particularly patients with COVID-19 that have required medical attention, tend to develop long COVID-19. And the symptoms that more commonly occur with patients with long COVID-19 are fatigue, decreased exhale capacity, and shortness of breath.
So, from there [was] the idea of implementing an exercise rehabilitation program for these patients. The problem is that the availability of hospital-based supervised programs, physical rehab programs, is very limited, [and] from here [was] the idea of developing a home-based program. Now, what is attractive about that is that this type of program probably can be implemented when a future pandemic may happen.
The other thing that pressed us to develop this program was that we noticed the reluctance of patients during the COVID-19 pandemic to come to the hospital and to clinics, and from here [came] the idea of developing something that could be delivered in the home environment.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More